EUVIMEDOpdag EUVIMED
Crossref

Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice

Sait Ashina iD

Headache: The Journal of Head and Face Pain · 2026-07 · 66 (7) · 1657-1659

DOI: 10.1111/head.70151 ↗

At a glance

Journal article in Headache: The Journal of Head and Face Pain, published online on 2026-06-14. Written by Sait Ashina. Institution: Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. 9 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

Author keywords

CGRPPACAPcalcitonin gene‐related peptide‐targeting treatmentmigrainepituitary adenylate cyclase‐activating polypeptide‐targeting treatmentprevention

Authors and institutions

  • Department of Neurology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
  • Department of Anesthesia, Critical Care and Pain Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

ORCID profiles: Sait Ashina

Cite

APA

Ashina, S. (2026). Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice. Headache: The Journal of Head and Face Pain, 66(7), 1657-1659. https://doi.org/10.1111/head.70151

Vancouver

Ashina S. Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice. Headache: The Journal of Head and Face Pain. 2026;66(7):1657-1659. doi:10.1111/head.70151

BibTeX
@article{Ashina2026,
  author = {Ashina, Sait},
  title = {Pituitary adenylate cyclase–activating polypeptide blockade in migraine and the transformation of clinical practice},
  journal = {Headache: The Journal of Head and Face Pain},
  year = {2026},
  volume = {66},
  number = {7},
  pages = {1657--1659},
  doi = {10.1111/head.70151}
}
Start for free →